Trials / Conditions / Resistant Cancer
Resistant Cancer
7 registered clinical trials studyying Resistant Cancer — 4 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | A Clinical Trial of Firsekibart, Tislelizumab, and Lenvatinib in Patients With Unresectable, TP53-Mutated Hepa NCT07535840 | Tongji Hospital | N/A |
| Recruiting | Assessing Cancer Treatment Response to Therapy Using 18F-FSPG PET NCT05889312 | Guy's and St Thomas' NHS Foundation Trust | — |
| Recruiting | Autologous CAR-T Cells Targeting B7-H3 in PDAC NCT06158139 | UNC Lineberger Comprehensive Cancer Center | Phase 1 |
| Recruiting | Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells NCT06347068 | UNC Lineberger Comprehensive Cancer Center | Phase 1 |
| Unknown | Lenvatinib Plus VIC-1911 in Lenvatinib-unresponsive or Lenvatinib-resistant HCC NCT05718882 | RenJi Hospital | N/A |
| Unknown | Lorlatinib Combinations in Lung Cancer NCT04292119 | Massachusetts General Hospital | Phase 1 / Phase 2 |
| Active Not Recruiting | 9-ING-41 in Patients With Advanced Cancers NCT03678883 | Actuate Therapeutics Inc. | Phase 2 |